Instead, SCLC survive and proliferate largely reliant on the currently undruggable MYC family of transcription factors, and through the loss of tumor suppressors p53 and Rb [1], thus underlining the need for novel therapies towards the treatment of SCLC. The gene discussed is RB1; the disease is small cell lung carcinoma.